During the past decade, Oncology Specialists of Charlotte conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 25 clinical trials were completed, i.e. on average, 64.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 24 clinical trials were completed. i.e. 480% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Specialists of Charlotte" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Specialists of Charlotte" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Specialists of Charlotte" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (6 trials), "Ovarian Serous Adenocarcinoma" (3 trials) and "Primary Peritoneal Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Oncology Specialists of Charlotte" in a lesser frequency.

Most popular intervention types in "Oncology Specialists of Charlotte" are "Drug" (44 trials), "Other" (34 trials), "Biological" (16 trials), "Procedure" (9 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (9 trials), "Docetaxel" (8 trials), "Questionnaire Administration" (7 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Specialists of Charlotte" are 40 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Specialists of Charlotte". undefined are not yet recruiting, 9 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Oncology Specialists of Charlotte, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Specialists of Charlotte, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".